WuXi AppTec

Global Platform
One Vision

Our Vision

Every Drug Can Be Made
and Every Disease Can Be Treated

By Building an Open-access Platform with the Most Comprehensive Capabilities and Technologies in the Global Healthcare Industry

Our Values

Integrity & Dedication, Working Together & Sharing Success;
Doing the Right Thing, Doing It Right.

About Us

Enabling Innovation

Established in December 2000, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,700 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".

Services and Solutions

An Open Enabling Platform

Enabling more than 3,700 Innovative Collaborators from more than 30 Countries

icon

Small Molecule Drug R&D and Manufacturing

icon

Cell Therapy
and Gene Therapy

icon

Drug R&D and Medical
Device Testing

icon

Clinical
Services

icon

Small Molecule Drug R&D and Manufacturing

Company Platform

Enabling Anyone, Any Company

To Become the Most Comprehensive Capability and Technology Platform in the Global Pharmaceutical and Healthcare Industry

Research Service Division

Providing comprehensive
end-to-end drug discovery solutions

Laboratory Testing Division

Providing integrated testing solutions for drug development and medical device innovation

STA Pharmaceutical

Global leading platform for pharmaceutical development and manufacturing

Advanced Therapies Unit

Cell therapy and gene therapy R&D and production platform

WuXi Clinical

Providing global clinical development solutions, with dedicated resources in 60+ countries

WuXi SMO

Clinical trial site operation for Phase I-IV pharmaceutical and medical device study

LabNetwork

Global e-commerce platform linking R&D products, suppliers and buyers

News

The Latest News about WuXi AppTec

Dr. Ge Li Awarded “CEO of the Year” at CPhI Worldwide 2019

WuXi AppTec Receives Investment Grade Corporate Ratings from Three Global Rating Agencies

WuXi AppTec Reports Third-Quarter 2019 Results

WuXi STA's Jinshan Facility Passes EMA Inspection

WuXi AppTec Research Service Division and BioSolveIT Introduce GalaXi®, a Vast New Chemical Space of Tangible Molecules

WuXi AppTec Launches DNA Encoded Library (DEL) Service Package “DELight” to Expedite Early Drug Discovery

Careers

Welcome to

Our Team

Become Part of Creating a Better Life

Investors

The Latest Financial Reports, Announcements and Resources